martes, 24 de abril de 2018

A Potential Anticancer Drug From Poppies Has Been Produced in Genetically Engineered Yeast | NCCIH

A Potential Anticancer Drug From Poppies Has Been Produced in Genetically Engineered Yeast | NCCIH

National Center for Complementary and Integrative Health (NCCIH)

Poppy



Researchers from Stanford University and collaborating institutions have successfully synthesized noscapine, a potential anticancer drug, in yeast cells. This research, which was partially supported by the National Center for Complementary and Integrative Health, was published in a recent issue of the Proceedings of the National Academy of Sciences.

Noscapine, a nonnarcotic cough suppressant that is also being investigated as a potential anticancer drug, currently has only one source—the opium poppy. Because environmental factors such as pests, disease, and climate can threaten the poppy crop, which is only grown in a limited geographic area, other ways of producing noscapine are needed to ensure a stable supply of the drug.

Read the full Research Spotlight

No hay comentarios:

Publicar un comentario